Get the Facts

Find what you need to know
in our brochures.


Get our
Press Kit

Official information for
articles and stories.


Multiple Myeloma News

Sort by Category:

Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A

Sarkar S, van Gelder M, Noort W, Xu Y, Rouschop KM, Groen R, Schouten HC, Tilanus MG, Germeraad WT, Martens AC, Bos GM, Wieten L. Cancer Immunol Immunother. 2015 Aug;64(8):951-63. doi: 10.1007/s00262-015-1694-4. Epub 2015 Apr 29. PMID: 25920521 [PubMed - in process] Read More

August 20, 2015

Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study

McCann KJ, Godeseth R, Chudley L, Mander A, Di Genova G, Lloyd-Evans P, Kerr JP, Malykh VB, Jenner MW, Orchard KH, Stevenson FK, Ottensmeier CH. Cancer Immunol Immunother. 2015 Aug;64(8):1021-32. doi: 10.1007/s00262-015-1703-7. Epub 2015 May 16. PMID: 25982371 [PubMed - in process] Free PMC Article Read More

August 20, 2015

Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

Lonial S, Dimopoulos M, Palumbo A, White D, Grosicki S, Spicka I, Walter-Croneck A, Moreau P, Mateos MV, Magen H, Belch A, Reece D, Beksac M, Spencer A, Oakervee H, Orlowski RZ, Taniwaki M, Röllig C, Einsele H, Wu KL, Singhal A, San-Miguel J, Matsumoto M, Katz J, Bleickardt E, Poulart V, Anderson KC, Richardson P; ELOQUENT-2 Investigators. N Engl J Med. 2015 Aug 13;373(7):621-31. doi: 10.1056/NEJMoa1505654. Epub 2015 Jun 2. PMID: 26035255 [PubMed - in process] Read More

August 20, 2015

Page 1 of 5612345...102030...Last »